Current Strategies for Brain Drug Delivery

Overview

Journal Theranostics

Date 2018 Mar 21

PMID 29556336

Citations 314

Authors

Xiaowei Dong

Affiliations

Soon will be listed here.

Abstract

The blood-brain barrier (BBB) has been a great hurdle for brain drug delivery. The BBB in healthy brain is a diffusion barrier essential for protecting normal brain function by impeding most compounds from transiting from the blood to the brain; only small molecules can cross the BBB. Under certain pathological conditions of diseases such as stroke, diabetes, seizures, multiple sclerosis, Parkinson's disease and Alzheimer disease, the BBB is disrupted. The objective of this review is to provide a broad overview on current strategies for brain drug delivery and related subjects from the past five years. It is hoped that this review could inspire readers to discover possible approaches to deliver drugs into the brain. After an initial overview of the BBB structure and function in both healthy and pathological conditions, this review re-visits, according to recent publications, some questions that are controversial, such as whether nanoparticles by themselves could cross the BBB and whether drugs are specifically transferred to the brain by actively targeted nanoparticles. Current non-nanoparticle strategies are also reviewed, such as delivery of drugs through the permeable BBB under pathological conditions and using non-invasive techniques to enhance brain drug uptake. Finally, one particular area that is often neglected in brain drug delivery is the influence of aging on the BBB, which is captured in this review based on the limited studies in the literature.

Citing Articles

Intranasal Mucoadhesive In Situ Gel of Glibenclamide-Loaded Bilosomes for Enhanced Therapeutic Drug Delivery to the Brain.

Tripathi M, Gharti L, Bansal A, Kaurav H, Sheth S Pharmaceutics. 2025; 17(2).

PMID: 40006560 PMC: 11859129. DOI: 10.3390/pharmaceutics17020193.

Evaluation of blood-tumor barrier permeability and doxorubicin delivery in rat brain tumor models using additional focused ultrasound stimulation.

Choi H, Han M, Jung B, Huh H, Lee E, Choi J Sci Rep. 2025; 15(1):6592.

PMID: 39994241 PMC: 11850853. DOI: 10.1038/s41598-025-88379-5.

Nebulized seabuckthorn seed oil inhalation attenuates Alzheimer's disease progression in APP/PS1 mice.

Ren R, Zhang G, Ma J, Zheng Y, Zhao Y, Zhang Y Sci Rep. 2025; 15(1):6368.

PMID: 39984555 PMC: 11845625. DOI: 10.1038/s41598-025-89747-x.

Antimicrobial cyclic peptides effectively inhibit multiple forms of Borrelia and cross the blood-brain barrier model.

Mochnacova E, Bhide K, Kuckova K, Jozefiakova J, Malarik T, Bhide M Sci Rep. 2025; 15(1):6147.

PMID: 39979461 PMC: 11842550. DOI: 10.1038/s41598-025-90605-z.

A review on the role of nanoparticles for targeted brain drug delivery: synthesis, characterization, and applications.

Mohammed P, Hussen N, Hasan A, Salh H, Jamalis J, Ahmed S EXCLI J. 2025; 24:34-59.

PMID: 39967907 PMC: 11830919. DOI: 10.17179/excli2024-7163.

References

Zhou W, Zhang J, Wang G, Ling L, Yan C . Permeability and distribution of nerve growth factor in the brain of neonatal rats by periphery venous injection in hypoxic-ischemic state. Springerplus. 2016; 5(1):1893. PMC: 5084138. DOI: 10.1186/s40064-016-3594-2. View

Shiraishi K, Kawano K, Minowa T, Maitani Y, Yokoyama M . Preparation and in vivo imaging of PEG-poly(L-lysine)-based polymeric micelle MRI contrast agents. J Control Release. 2009; 136(1):14-20. DOI: 10.1016/j.jconrel.2009.01.010. View

Masserini M . Nanoparticles for brain drug delivery. ISRN Biochem. 2015; 2013:238428. PMC: 4392984. DOI: 10.1155/2013/238428. View

Bhat R, Crowe E, Bitto A, Moh M, Katsetos C, Garcia F . Astrocyte senescence as a component of Alzheimer's disease. PLoS One. 2012; 7(9):e45069. PMC: 3440417. DOI: 10.1371/journal.pone.0045069. View

Sahin D, Ugur Yilmaz C, Orhan N, Arican N, Kaya M, Gurses C . Changes in electroencephalographic characteristics and blood-brain barrier permeability in WAG/Rij rats with cortical dysplasia. Epilepsy Behav. 2017; 67:70-76. DOI: 10.1016/j.yebeh.2016.11.001. View

Prados M, Schold Jr S, Fine H, Jaeckle K, Hochberg F, Mechtler L . A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma. Neuro Oncol. 2003; 5(2):96-103. PMC: 1920676. DOI: 10.1093/neuonc/5.2.96. View

Chen H, Kim S, Li L, Wang S, Park K, Cheng J . Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging. Proc Natl Acad Sci U S A. 2008; 105(18):6596-601. PMC: 2373326. DOI: 10.1073/pnas.0707046105. View

Cook R, Householder K, Chung E, Prakapenka A, DiPerna D, Sirianni R . A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system. J Control Release. 2015; 220(Pt A):89-97. PMC: 4688251. DOI: 10.1016/j.jconrel.2015.10.013. View

Check E . Gene therapy put on hold as third child develops cancer. Nature. 2005; 433(7026):561. DOI: 10.1038/433561a. View

10.

Jiang Y, Brynskikh A, S-Manickam D, Kabanov A . SOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature. J Control Release. 2015; 213:36-44. PMC: 4684498. DOI: 10.1016/j.jconrel.2015.06.021. View

11.

Medina D, Householder K, Ceton R, Kovalik T, Heffernan J, Shankar R . Optical barcoding of PLGA for multispectral analysis of nanoparticle fate in vivo. J Control Release. 2017; 253:172-182. DOI: 10.1016/j.jconrel.2017.02.033. View

12.

Villringer K, Sanz Cuesta B, Ostwaldt A, Grittner U, Brunecker P, Khalil A . DCE-MRI blood-brain barrier assessment in acute ischemic stroke. Neurology. 2016; 88(5):433-440. DOI: 10.1212/WNL.0000000000003566. View

13.

Singh V, Subudhi B . Development and characterization of lysine-methotrexate conjugate for enhanced brain delivery. Drug Deliv. 2014; 23(7):2327-2337. DOI: 10.3109/10717544.2014.984369. View

14.

Ahmed S, Li H, Cao C, Sikoglu E, Denninger A, Su Q . A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS Gene therapy in Canavan mice. Mol Ther. 2013; 21(12):2136-47. PMC: 3863789. DOI: 10.1038/mt.2013.138. View

15.

Wang X, Xue G, Liu W, Shu H, Wang M, Sun Y . Melatonin alleviates lipopolysaccharide-compromised integrity of blood-brain barrier through activating AMP-activated protein kinase in old mice. Aging Cell. 2017; 16(2):414-421. PMC: 5334533. DOI: 10.1111/acel.12572. View

16.

Zhu J, Dong X . Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation. J Vis Exp. 2017; (123). PMC: 5608011. DOI: 10.3791/55584. View

17.

Wohlfart S, Gelperina S, Kreuter J . Transport of drugs across the blood-brain barrier by nanoparticles. J Control Release. 2011; 161(2):264-73. DOI: 10.1016/j.jconrel.2011.08.017. View

18.

Renu A, Laredo C, Lopez-Rueda A, Llull L, Tudela R, San-Roman L . Vessel Wall Enhancement and Blood-Cerebrospinal Fluid Barrier Disruption After Mechanical Thrombectomy in Acute Ischemic Stroke. Stroke. 2017; 48(3):651-657. DOI: 10.1161/STROKEAHA.116.015648. View

19.

Merali Z, Huang K, Mikulis D, Silver F, Kassner A . Evolution of blood-brain-barrier permeability after acute ischemic stroke. PLoS One. 2017; 12(2):e0171558. PMC: 5313141. DOI: 10.1371/journal.pone.0171558. View

20.

Shiraishi K, Wang Z, Kokuryo D, Aoki I, Yokoyama M . A polymeric micelle magnetic resonance imaging (MRI) contrast agent reveals blood-brain barrier (BBB) permeability for macromolecules in cerebral ischemia-reperfusion injury. J Control Release. 2017; 253:165-171. DOI: 10.1016/j.jconrel.2017.03.020. View